Target intelligence / Profile preview

Major histocompatibility complex, class II, DQ beta 3 (HLA-DQB3)

Target
HLA-DQB3
Molecular classification
Histocompatibility complex (HLA gene family), MHC class II beta chain (putative)
01

Overview

Major histocompatibility complex, class II, DQ beta 3 (HLA-DQB3) is a locus on chromosome 6 in humans associated with the class II region of the MHC, which typically encodes proteins involved in antigen presentation and adaptive immune interactions. Unlike other HLA-DQ beta chain genes, the sequence of HLA-DQB3 is missing several protein domains, making it unclear whether it produces a functional protein. Consequently, HLA-DQB3 is not widely recognized as a functional receptor or therapeutic target, and no drugs or biomarkers are linked to it. Its classification and nomenclature overlap with other functional HLA-DQ genes (such as HLA-DQB1), but the DQB3 locus is not included in standard HLA typing panels. For clinical or drug targeting purposes, other HLA class II proteins (e.g., HLA-DQB1, HLA-DRB1) are used instead. Key points: - HLA-DQB3 is a gene locus, not a confirmed functional protein target. - Its predicted biological role aligns with MHC class II antigen presentation, but there is insufficient evidence for protein expression or therapeutic relevance. - Many aliases exist, reflecting its complex genomic context.

Other names
D6S205D6S205EDVBDQB3HLA-DVBDVBETA
02

Mechanism of action

None known or established.

03

Biological functions

Adaptive immune response (predicted, not confirmed)Antigen processing and presentation (predicted, not confirmed)
04

Disease associations

None directly established. Other MHC class II loci are associated with autoimmune disease, inflammation, and infection, but data on DQB3 are lacking.
05

Safety considerations

None reported. No therapeutic utilization or safety literature exists.

Beyond the preview

Go deeper on Major histocompatibility complex, class II, DQ beta 3 (HLA-DQB3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Major histocompatibility complex, class II, DQ beta 3 (HLA-DQB3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call